rates of CVD and diabetes mellitus. It is unclear whether and how cigarette smoking contributes to the pathogenesis of atherosclerosis in American Indians. Elucidation of the biological pathways linking smoking to atherosclerosis will provide novel strategies for the prevention and treatment of CVD and its related conditions in this ethnically important but traditionally understudied population, as well as in many others where smoking and diabetes mellitus play roles in CVD risk.
Nicotine, the major bioactive component of cigarette smoke, affects the cardiovascular system through stimulating the sympathetic nerve pathways 12 and causes damages to the vascular wall and endothelial function. 13 Nicotine acts by binding to nicotinic acetylcholine receptors (nAChRs), a superfamily of ligand-gated ion channels that are widely present within neuronal and nonneuronal cell types. 14 Evidence from human and animal research has documented that genetic polymorphisms in nAChRs are associated with nicotine dependence 15 and lung cancer. 16 However, little research has been done to investigate the potential impact of the nAChRs variants on susceptibility to subclinical atherosclerosis. Moreover, existing studies focused on single gene analysis, which is less powerful in detecting variants with small genetic effect and cannot capture the joint contribution of multiple genes. The goal of this study is to conduct a gene-family analysis to examine the joint impact of 61 tag single-nucleotide polymorphisms (SNPs) from 7 nAChRs genes on preclinical CVD assessed by carotid intima-media thickness (IMT) and plaque score in a large, well-characterized American Indian population.
Methods

Study Population
This study used data from the Strong Heart Family Study (SHFS), a multicenter, family-based prospective study designed to identify genetic factors for CVD and diabetes mellitus and their risk factors in American Indians. Detailed descriptions of the SHFS protocols for the collection of phenotype data have been described previously. 1 Briefly, a total of 3665 tribal members (≥18 years of age) from 94 families residing in Arizona (AZ), North and South Dakota (DK), and Oklahoma (OK) were recruited and examined between 2001 and 2003. Among the 94 families, 76 are 3-generation pedigrees (26 from AZ, 28 from OK, and 22 from DK) and 18 are 2-generation pedigrees (5 from AZ, 8 from OK, and 5 from DK). The largest family size is 113 individuals from DK, 61 from OK, and 80 from AZ, with an average family size of 38 (37 in AZ, 34 in OK, and 45 in DK). The largest sibling size is 9 in DK, 9 in OK, and 10 in AZ. The SHFS protocols were approved by the Institutional Review Boards from the Indian Health Service and the participating centers. All participants underwent a personal interview to collect data on demographic characteristics, medical history, and lifestyle risk factors, including smoking, alcohol consumption, diet, and physical activity. A physical examination was given to each participant, including anthropometric and blood pressure measurements and an examination of the heart and lungs. Laboratory methods were reported previously. 1, 17 All participants have given informed consent for genetic study of CVD, diabetes mellitus, and associated risk factors.
Subclinical Atherosclerosis Assessment
All study participants underwent carotid ultrasonography using Acuson Sequoia machines equipped with 7 MHz vascular probes on the day of the study visit using a standardized protocol as described previously. 18, 19 Briefly, the extracranial segments of the left and right carotid arteries were extensively scanned for the presence of discrete atherosclerotic plaque, defined as focal protrusion (IMT) with a thickness exceeding that of the surrounding wall by 50%. Plaque score, a measure of the extent of atherosclerosis, was calculated by the number of left and right segments (common carotid, bulb, internal carotid, and external carotid) containing plaque, thus plaque score ranged from 0 to 8. IMT of the far wall of the distal common carotid artery was measured at the end diastole on multiple cycles of M-mode images. IMT was never measured at the level of a plaque, and the average of the left and right values was used in statistical analyses. All ultrasound measurements were performed by trained research sonographers and interpreted by a single highly experienced cardiologist who was blinded to the clinical characteristics of the participants.
Measurements of Coronary Risk Factors
A detailed description for the collection and measurement of coronary risk factors was reported previously. 1 Briefly, cigarette smoking was assessed via questionnaire, and participants were grouped as smokers (former and current smoker) versus never smokers. Pack-years were calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked. Participants were categorized into current drinkers, former drinkers, and never drinkers based on their history of alcohol consumption. Physical activity was assessed by the mean number of steps per day calculated by averaging the total number of steps recorded each day during the 7-day period. Body mass index was calculated by dividing weight in kilograms by the square of height in meters. Hypertension was defined as blood pressure levels of 140/90 mm Hg or higher or use of antihypertensive medications. According to the 1997 American Diabetes Association criteria, 20 diabetes mellitus was defined as fasting plasma glucose ≥7.0 mmol/L or receiving insulin or oral hyperglycemic treatment. Impaired fasting glucose was defined as a fasting glucose of 6.1 to 7.0 mmol/L. Fasting glucose <6.1 mmol/L was defined as normal.
Tag SNP Selection and Genotyping
A total of 61 tag SNPs in 7 nAChRs genes (CHRNA3-A6, CHRNB2-B4) were selected and genotyped in 3665 participants from the SHFS. These genes were consistently reported to be associated with cigarette smoking in previous studies. Information for these SNPs has been described in our previous study. 21 To choose tag SNPs in each candidate gene, we used the computer program Haploview 4.2 22 with an r 2 threshold of 0.80 for linkage disequilibrium. The following criteria were also considered: minor allele frequency, SNP location (ie, coding region), and Illumina design scores (quantifying how likely an SNP can be genotyped). SNPs that could not be tagged (ie, singletons) were included as long as their design scores were >0.15. All genotyping was done at the Texas Biomedical Research Institute using the Illumina VeraCode technology (Illumina, Inc., San Diego, CA). The average genotyping call rates were >98% for the 61 tag SNPs, and sample success rate was 99.5%.
Statistical Analysis
Single SNP Association Analysis
The association of each SNP with IMT or plaque score, separately, was assessed using the computer program Family-based Association Test, 23, 24 adjusting for age, sex, study center (AZ versus OK versus DK), smoking status (ever smokers versus never), alcohol intake (current versus former versus never), waist:hip ratio, diabetes mellitus status, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, systolic blood pressure, levels of physical activity, plasma fibrinogen, and renal function (assessed by estimated glomerular filtration rate). Carotid plaque score, which ranges from 0 to 8, was treated as a continuous variable in the analysis by Family-based Association Test, which was reported to be robust to the distribution of response variables. 23, 25, 26 Gene-based and Gene-Family Analysis
We examined the association of a candidate gene (including all SNPs with the gene) with IMT or plaque score by combining P values from single SNP association analysis. The gene-based association was assessed by the truncated product method. 27 A gene-family analysis was then performed by combining the P value of each gene obtained from gene-based analysis, including all 7 genes in the nAChRs family. The truncated product method has been evaluated extensively by simulation studies, 28 and its application to determine gene-based or gene-family associations has been described recently. 21 
Sensitivity Analyses
To evaluate the impact of diabetes mellitus on the association between genetic variants and subclinical atherosclerosis, we conducted separate analyses in diabetic patients and normal controls (those with normal fasting glucose). To examine whether the gene-based or genefamily associations are primarily driven by the most significant SNPs, we conducted sensitivity analysis by removing these SNPs from gene-based or gene-family analysis. We also performed sensitivity analysis to investigate how different truncation points of P values in truncated product method affect the statistical significance of genebased or gene-family analysis by assuming different truncation cutoffs. In addition, to examine whether cigarette smoking per se affects the relationship between genetic variants and IMT or plaque score, we performed sensitivity analysis by comparing results with or without adjustment for smoking status. Multiple testing was corrected using the adjusted false-discovery rate, 29 and statistical significance was defined as false-discovery rate-corrected P<0.05. To improve normality, continuous variables were logarithmically transformed before statistical analyses. Participants with missing information on smoking status or subclinical measures were excluded from statistical analyses (n=84). Analyses were done using Matlab 7.10.0.499 (The MathWorks, Inc., Natick, MA). Table 1 presents the baseline characteristics of the study participants according to smoking status. Compared with never smokers, smokers were older, more likely to be men, and more likely to be centrally obese. No significant difference in IMT or plaque score was observed between smokers and never smokers.
Results
Baseline Characteristics of the Study Participants
Results for Single SNP Association Analysis
Information on the 61 SNPs and their linkage disequilibrium patterns were reported elsewhere. 21 We found evidence for a different genetic architecture among study participants from the 3 study centers, suggesting a possible population admixture among our study participants. However, this should not be an issue for our analysis because we used the Family-based Association Test that is robust to population substructure. 25 Of the 61 SNPs examined, multiple SNPs showed individual association with IMT or plaque score. For example, 4 SNPs in CHRNA3, 2 SNPs in CHRNA4, 6 SNPs in CHRNA5, 2 SNPs in CHRNB2, 1 SNP in CHRNB3, and 5 SNPs in CHRNB4 were significantly associated with IMT, whereas 1 SNP in CHRNA3, 1 SNP in CHRNA4, 3 SNPs in CHRNA5, 1 SNP in CHRNA6, 4 SNPs in CHRNB2, 1 SNP in CHRNB3, and 5 SNPs in CHRNB4 were associated with plaque score. However, only 3 low-frequency SNPs (rs3811450 in CHRNB2, rs4952 in CHRNB3, and rs12914008 in CHRNB4; minor allele frequencies, 1.6%, 1.4%, and 0.6%, respectively) survived correction for multiple testing. All 3 SNPs are in Hardy-Weinberg equilibrium (all Ps>0.95 based on χ 2 test). Results for single SNP association analysis with IMT and plaque score are shown in Tables 2 and   3 , respectively. The associations of the 3 low-frequency SNPs with IMT and plaque score are presented in Table 4 . Table 5 shows the results of gene-based and gene-family analyses. For gene-based analysis, variants in 3 genes (CHRNB2, CHRNB3, and CHRNB4) significantly contribute to susceptibility for IMT and plaque score (all Ps≤0.0004). Gene-family analysis comprising all 7 genes demonstrates that the nAChRs gene family was significantly associated with both IMT and plaque score (both Ps<10 
Results for Gene-based and Gene-Family Analysis
Results for Sensitivity Analyses
Diabetes mellitus is an important risk factor for CVD in American Indians. To examine whether diabetes mellitus modifies the association of nAChR genetic variants with subclinical atherosclerosis, we stratified our analyses by diabetic status. Results for single SNP association analysis stratified by diabetes mellitus are shown in online-only Data Supplement Tables I and II for IMT and plaque score, respectively. Results for gene-based and gene-family association analyses, stratified by diabetes mellitus status, are shown in online-only Data Supplement Tables III and IV, respectively. We observed differential effects of diabetes mellitus on the gene-based associations. For example, among participants with normal fasting glucose, 2 additional genes (CHRNA3 and CHRNA5) were significantly associated with plaque score but not IMT, whereas another gene (CHRNA4) showed significant association with IMT but not plaque score. However, this pattern was not observed among patients with diabetes mellitus. It seems that diabetes mellitus also modifies the association of single SNP with subclinical atherosclerosis. For instance, the statistical significance for the associations of 3 SNPs (rs3811450 in CHRNB2, rs4952 in CHRNB3, and rs12914008 in CHRNB4) with IMT exceed genome-wide significant level (P<10 −13 ) among subjects with normal fasting glucose but not among those with diabetes mellitus (although the associations are also statistically significant). After removing the 3 most significant SNPs (rs3811450, rs4952, and rs12914008) and correcting for multiple testing, the associations of CHRNB2 and CHRNB3 with IMT or plaque score substantially attenuated. The P values for the associations of CHRNB4 gene with IMT or plaque score were reduced but remained statistically significant. The gene-family association also remained statistically significant after removing the 3 most significant SNPs from gene-family analysis (Table 5 ). Our sensitivity analysis also indicates that the statistical significance of gene-based or gene-family analysis is quite robust to the different truncation points of P values for truncated product method analysis (online-only Data Supplement Table V ). In addition, no significant difference was observed in the relationship between nAChRs variants and subclinical atherosclerosis between ever smokers and never smokers, suggesting that these genetic variants may influence the susceptibility of atherosclerosis through pathways beyond cigarette smoking per se.
Discussion
In a sample of 3665 American Indians who participated in the SHFS, we conducted gene-based and gene-family analyses to examine the joint associations of 61 tag SNPs in 7 nAChRs genes with preclinical atherosclerosis. We found that, although multiple SNPs showed individual nominal or marginal associations with IMT and plaque score, only a few survived corrections for multiple testing. However, a gene-family analysis considering the joint contribution of multiple SNPs revealed a significant association of the gene family with both IMT and plaque score. To our best knowledge, this is the first study examining the joint contribution of multiple candidate genes involved in the nAChRs pathway to the susceptibility of atherosclerosis in any ethnic groups.
Several aspects of our investigation merit comment. First, our study demonstrated that a single SNP may show no or marginal association with IMT or plaque score, but the joint impact of multiple SNPs within a gene or a pathway on disease susceptibility could be substantial. For example, after correcting for multiple testing, no SNP in the CHRNA4 gene was individually associated with IMT among participants with normal fasting glucose, but gene-based analysis revealed a significant association of this gene with IMT. Similarly, no SNP in CHRNA3 or CHRNA5 showed individual association with plaque score among subjects with normal fasting glucose, but gene-based analysis demonstrated significant associations of these 2 genes with plaque score (online-only Data Supplement Table III) . This is consistent with previous studies demonstrating that, for complex traits involving multiple variants, the contribution of a single genetic polymorphism could be small, but statistical approaches that take into account the cumulative effect of multiple variants, such as a gene-family analysis used in this study, could capture the joint contribution of many variants simultaneously and thus provides a better opportunity in identifying disease genes. Second, previous studies repeatedly reported an association of rs16969968 in the CHRNA5 gene with nicotine dependence in European Americans or African Americans. 16, 31 Our analyses, however, found only a nominal association of this SNP with IMT or carotid plaque score, probably owing to difference in genetic background between American Indians and other ethnic populations. It is also possible that this SNP influences subclinical atherosclerosis through pathways beyond cigarette smoking. Third, the gene cluster CHRNA3/CHRNA5/ CHRNB4, located on chromosome 15q24, was consistently reported to be associated with nicotine dependence. 32, 33 Although the CHRNB4 gene showed strong association with both IMT and plaque score, we did not detect a significant association of CHRNA3 or CHRNA5 with subclinical atherosclerosis by either single gene analysis or gene-family analysis. However, our sensitivity analyses revealed that this gene cluster was significantly associated with the extent of atherosclerosis among participants with normal fasting glucose levels, indicating that the effect of this gene cluster on subclinical atherosclerosis might be mediated through blood glucose regulation, a known mechanism involved in CVD. 34 However, it is unclear why this association was not observed in patients with diabetes.
30
In this study, we detected significant associations of 3 low-frequency variants (rs3811450, rs4952, and rs12914008; minor allele frequencies, 1.6%, 1.4%, and 0.6%, respectively) with both carotid IMT and plaque score. Although these SNPs (or their nearby SNPs that are in high linkage disequilibrium with them) were previously associated with nicotine response or nicotine dependence, 16, 35, 36 neither was reported to be associated with subclinical atherosclerosis, thus our findings may represent novel rare variants with large effects on subclinical atherosclerosis in American Indians.
Both carotid IMT and plaque score are markers of subclinical vascular disease, but they might reflect different stages or severity of atherosclerosis. Compared with IMT, which measures the thickness of carotid artery, plaque score reflects the severity of irregular morphology and lumen narrowing, 37 and thus is considered a marker of advanced atherosclerosis. In our analysis, IMT was measured in the common carotid artery with the absence of plaque, thus providing a measure that could distinguish carotid IMT from plaque presence. This is different from previous studies that measured combined carotid and femoral artery IMT 38 or measured the wall thickness regardless of the absence or presence of plaque. 39 Using IMT measurement incorporating focal plaque thickness could potentially conflate the 2 entities and overestimate the effect of IMT. 40 Interestingly, it seems that genetic associations at several SNP loci are stronger with IMT than with plaque score. This observation is in line with previous studies demonstrating a higher heritability of IMT than plaque score 41 and may suggest that the studied genes could have a larger effect on earlier atherosclerosis (as measured by IMT) than on advanced atherosclerosis (as assessed by plaque presence). It is also probable that these genes may affect wall thickening through other as yet unknown pathways. This finding does not contradict with previous studies reporting a stronger prognostic value of carotid plaque than IMT in predicting CVD events, 42 including research from our study population. 40 Although smokers tend to be thinner than nonsmokers, 43 they are more likely to have increased abdominal obesity, 44 a strong risk factor for carotid atherosclerosis. 45 The mechanism underlying the association between smoking and body weight remains unclear, with a recent study indicating that, by activation of hypothalamic α 3 β 4 nAChRs, smoking can stimulate the activity of proopiomelanocortin, resulting in a decreased appetite and body weight. 46 In this study, we did not observe a significant difference in body mass index among ever smokers and never smokers, but the waist:hip ratio was significantly higher in ever smokers than never smokers. However, our results are unlikely to be confounded by central obesity because we adjusted for waist:hip ratio in all statistical analyses.
The biological mechanisms through which nAChRs gene variants influence atherosclerosis are unclear. According to our results, it seems that cigarette smoking per se may not cause atherosclerosis directly because we controlled for smoking in all statistical analyses. However, given previous evidence for nicotine toxicity in vascular system, 7,10 this hypothesis needs to be confirmed in future research. Given the importance of nAChRs in neuronal function, 47 it is possible that cigarette smoking could affect CVD risk through the central nervous system. 46 Moreover, because atherosclerosis is an inflammatory process 48 and smoking increases inflammation, 49 it is also plausible that these genetic variants may influence carotid atherosclerosis through their impact on inflammatory responses to cigarette smoking. In this study, we did observe a higher level of plasma fibrinogen in smokers than in never smokers (although the difference was statistically insignificant), but no difference in IMT and plaque score was observed between these 2 groups. Alternatively, the nAChR genetic variations may influence atherogenesis through smoking-induced oxidative stress. 50 Of course, it is also possible that these nAChRs variants could affect carotid atherosclerosis through other independent yet uncharacterized mechanisms.
Our study has a few limitations. First, although we were able to control many of the potential confounders, we cannot rule out entirely the possibility of residual confounding by other unknown or unmeasured factors. Second, this study used a cross-sectional design, which precluded any causal inference. Third, IMT was measured only in the distal common carotid artery, and thus the association of genetic variants with bifurcation or internal carotid IMT cannot be assessed. Finally, our analyses were undertaken among a cohort of a single ethnic group and thus need to be replicated in other study populations.
In summary, this study provides initial evidence that multiple genetic variants in the nAChRs gene family jointly contribute to the susceptibility of subclinical atherosclerosis in American Indians participated in the SHFS. The genetic effect of these polymorphisms on atherosclerosis is likely mediated by pathways beyond cigarette smoking per se. Our results may provide valuable information for individualized prevention or intervention on atherosclerosis in American Indians who experience a disproportionately high prevalence of CVD and diabetes mellitus. †P values after removing the 3 most significant single-nucleotide polymorphisms (rs3811450, rs4952, and rs12914008). 
